- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | ONO Pharmaceutical Buying Deciphera Pharmaceuticals For $2.4 Billion | 1 | pulse2.com | ||
| Di | Ono Pharmaceutical co., ltd.: ONO Enters into a Definitive Agreement to Acquire Deciphera Pharmaceuticals | 61 | PR Newswire | OSAKA, Japan, April 30, 2024 /PRNewswire/ -- ONO Pharmaceutical, Co., Ltd., (TSE: 4528, Representative Director, Chairman of the Board and Chief Executive Officer: Gyo Sagara, "ONO") and Deciphera... ► Artikel lesen | |
| Di | Japan's Ono Pharma to Buy U.S. Startup Deciphera | 2 | nippon.com | ||
| Di | Japan's Ono Pharma says $2.4 billion Deciphera purchase 'first step' for global expansion | 3 | Reuters | ||
| Mo | Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn | 5 | Pharmaceutical Technology | ||
| Mo | Ono Pharma's Plan to Become a Global Player Picks Up a New Piece With $2.4B Deciphera Acquisition | 2 | MedCity News | ||
| Mo | Ono Pharmaceutical to Acquire Deciphera for $2.4B | 2 | Contract Pharma | ||
| Mo | ONO to buy Deciphera Pharmaceuticals at a huge premium | 1 | iNVEZZ.com | ||
| Mo | Deciphera Catapults 72% After Ono Pharmaceutical Agrees To Buy It For $2.4 Billion | 3 | Investor's Business Daily | ||
| Mo | Japan's Ono pays $2.4B for Qinlock-maker Deciphera as biotech readies another approval run | 1 | FiercePharma | ||
| Mo | Deciphera Up In Pre-market On News Of Acquisition By ONO Pharmaceutical For About $2.4 Bln | - | RTTNews | ||
| Mo | Ono swoops on Deciphera in $2.4 billion takeover | 1 | pharmaphorum | ||
| Mo | Deciphera Pharma rises as co to be acquired by ONO Pharmaceutical for $2.4 billion | 3 | Reuters | ||
| Mo | Deciphera stock soars after Ono Pharmaceutical's $2.4B buyout deal | 3 | Seeking Alpha | ||
| Mo | ONO To Acquire Deciphera; Total Equity Value Of Deal At Approx. $2.4 Bln | 2 | RTTNews | ||
| Mo | Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion | 81 | Business Wire | WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve... ► Artikel lesen | |
| Fr | PRISM, ONO to co-create development candidate for oncology target | 2 | Pharmaceutical Business Review | ||
| 01.04. | Equillium's lupus drug improves kidney biomarker, teeing up opt-in decision from Ono | 9 | FierceBiotech | ||
| 14.03. | Sibylla Biotech Enters a Strategic Drug Discovery Collaboration with Ono Pharmaceutical in Central Nervous System Disorders | 323 | Business Wire | Sibylla Biotech announced today a drug discovery collaboration with Ono Pharmaceutical Co., Ltd. (TSE: 4528) that will access Sibylla's cutting-edge Pharmacological Protein Inactivation by Folding... ► Artikel lesen | |
| 06.03. | Ono signs licence deal with NEX-I for cancer therapy | 2 | Pharmaceutical Technology |
Seite:
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GILEAD SCIENCES | 60,81 | -0,44 % | Gilead Sciences Aktie: Quartalsverlust trotz Umsatzwachstum | Im ersten Quartal 2024 verzeichnete Gilead Sciences, ein Biopharmaunternehmen mit Fokus auf lebensbedrohlichen Infektionserkrankungen, trotz eines Umsatzanstiegs einen deutlichen Verlust pro Aktie.... ► Artikel lesen | |
| CANOPY GROWTH | 10,680 | -23,39 % | Aurora Cannabis & Canopy Growth stürzen ab - was ist los? | Um mehr als -20% sind am deutschen Feiertag die Aurora Cannabis-Aktie (WKN: A2P4EC) und die Aktie von Canopy Growth (WKN: A140WQA) an der Nasdaq abgestürzt. Was ist los im Cannabis-Sektor? Und wie geht... ► Artikel lesen | |
| MERCK & CO | 120,60 | -0,33 % | Erfolg auf ganzer Linie: Die Kasse klingelt bei Merck & Co.: Pharmariese hebt Umsatzprognose für 2024 an! | © Foto: © 2023 Merck & CoMerck hat am Donnerstag positive Ergebnisse vorgelegt, die die Markterwartungen übertrafen. Dies ist auf robuste Umsätze mit seinem Krebsmedikament Keytruda und eine hohe Nachfrage... ► Artikel lesen | |
| JAGUAR HEALTH | 0,225 | +11,94 % | Jaguar Health, Inc.: Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease | Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and short bowel syndrome (SBS) with intestinal... ► Artikel lesen | |
| IQVIA | 212,40 | -1,94 % | IQVIA Holdings Inc. Q1 Profit Beats Estimates | WASHINGTON (dpa-AFX) - IQVIA Holdings Inc. (IQV) reported earnings for first quarter that beat the Street estimates.The company's bottom line totaled $288 million, or $1.56 per share. This compares... ► Artikel lesen | |
| MADRIGAL PHARMACEUTICALS | 193,75 | +1,31 % | Madrigal Pharmaceuticals, Inc.: Madrigal Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | CONSHOHOCKEN, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH)... ► Artikel lesen | |
| INTERCEPT PHARMACEUTICALS | 17,520 | 0,00 % | Intercept Pharmaceuticals, Inc.: Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva (obeticholic acid) for the Treatment of PBC | sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from post-marketing studies COBALT and Study 401 as... ► Artikel lesen | |
| AZENTA | 49,000 | -0,41 % | Azenta Reports First Quarter Results for Fiscal 2024, Ended December 31, 2023 | BURLINGTON, Mass., Feb. 7, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2023 .
Quarter... ► Artikel lesen | |
| ALMIRALL | 8,505 | -0,35 % | Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases | Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare dermatological and other diseases associated with nonsense mutationsZKN-013 is a phase I ready... ► Artikel lesen | |
| PROTHENA | 20,400 | +5,70 % | Prothena Corporation plc: Prothena to Report First Quarter 2024 Financial Results on May 8 | Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced... ► Artikel lesen | |
| SPROUTLY CANADA | 0,011 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 09.04.2024 | The following instruments on XETRA do have their last trading day on 09.04.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 09.04.2024ISIN NameCA45790Y1043 INTELLABRIDGE TECH.CORP.XS2085883119... ► Artikel lesen | |
| PETIQ | 15,400 | +0,65 % | PetIQ, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | Record Full Year 2023 Net Sales Increase 19.6% Year-Over-Year to Over $1.1 BillionAdjusted EBITDA Exceeds Company's Full Year 2023 GuidanceReports Highest Annual Cash from Operations in the Company's... ► Artikel lesen | |
| FINANCIERE DE TUBIZE | 96,20 | +2,34 % | Financière de Tubize SA: Financière de Tubize - Dividend approval | Dividend confirmationRegulated information - 26 april 2024
The general shareholders meeting of 26 April 2024 has approved the annual accounts as at 31 December 2023, including the distribution of... ► Artikel lesen | |
| FUJI PHARMA | 9,500 | +1,60 % | Dividendenbekanntmachungen (28.03.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACOM CO LTD JP3108600002 6 JPY 0,0366 EUR ADVANEX INC JP3213400009 20 JPY 0,1222 EUR AICA KOGYO CO LTD JP3100800006 59 JPY 0... ► Artikel lesen | |
| BAYER | 28,420 | +3,91 % | Bayer: Neue Beschwerden wegen Glyphosat - so reagiert die Aktie | Trotz neuer Glyphosat-Vorwürfe gegen die Bayer AG setzt die Aktie des Leverkusener Chemie- und Pharmakonzerns ihre beachtliche Erholung am Donnerstagnachmittag unvermindert fort. Finanztreff.de blickt... ► Artikel lesen |
ONO PHARMACEUTICAL CO LTD ADR gehört der Branche Pharma an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 4,720 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
